CERT1 and cancer: To determine whether treatment of MIA PaCa-2, BxPC3, and Panc 1 cancer cells with GT3 favor the transport of newly synthesized ceramide to the Golgi, the levels of CERT and its phosphorylated form were probed by immunoblot.